| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-06 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-06 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.24 | 9e-06 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-06 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.13 | 3e-05 |